11-62881114-G-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001013251.3(SLC3A2):āc.91G>Cā(p.Ala31Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000267 in 1,608,456 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001013251.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC3A2 | NM_001013251.3 | c.91G>C | p.Ala31Pro | missense_variant | Exon 1 of 9 | ENST00000338663.12 | NP_001013269.1 | |
SLC3A2 | NM_001012662.3 | c.397G>C | p.Ala133Pro | missense_variant | Exon 4 of 12 | NP_001012680.1 | ||
SLC3A2 | NM_002394.6 | c.394G>C | p.Ala132Pro | missense_variant | Exon 4 of 12 | NP_002385.3 | ||
SLC3A2 | NM_001012664.3 | c.208G>C | p.Ala70Pro | missense_variant | Exon 2 of 10 | NP_001012682.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152258Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000505 AC: 12AN: 237710Hom.: 0 AF XY: 0.0000780 AC XY: 10AN XY: 128260
GnomAD4 exome AF: 0.0000275 AC: 40AN: 1456198Hom.: 0 Cov.: 31 AF XY: 0.0000304 AC XY: 22AN XY: 723722
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152258Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74384
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.397G>C (p.A133P) alteration is located in exon 4 (coding exon 4) of the SLC3A2 gene. This alteration results from a G to C substitution at nucleotide position 397, causing the alanine (A) at amino acid position 133 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at